BackCARGO Therapeutics Overview

CARGO Therapeutics Current Cash

CARGO Therapeutics's current cash is $110M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$107.75M
↓ 29.84% YoYΔ $-45.84M vs prior year quarter

Peer average

Loading

CARGO Therapeutics Current Cash History

Loading

CARGO Therapeutics vs. peers: Current Cash Comparison

Loading

CARGO Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CARGO Therapeutics (CRGX) FAQ

The latest current cash for CRGX is $110M as of June 2025. That compares with $150M in the prior-year period — down 29.8% year over year. Investors often review this figure alongside CARGO Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, CRGX's current cash moved from $150M to $110M — a 29.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CARGO Therapeutics's operating scale or balance-sheet position.

A current cash figure of $110M for CRGX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CRGX's current cash ($110M), review year-over-year change from $150M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.